261 related articles for article (PubMed ID: 10583004)
1. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation.
Alonso-Galicia M; Hudetz AG; Shen H; Harder DR; Roman RJ
Stroke; 1999 Dec; 30(12):2727-34; discussion 2734. PubMed ID: 10583004
[TBL] [Abstract][Full Text] [Related]
2. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries.
Alonso-Galicia M; Sun CW; Falck JR; Harder DR; Roman RJ
Am J Physiol; 1998 Sep; 275(3):F370-8. PubMed ID: 9729509
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles.
Sun CW; Alonso-Galicia M; Taheri MR; Falck JR; Harder DR; Roman RJ
Circ Res; 1998 Nov; 83(11):1069-79. PubMed ID: 9831701
[TBL] [Abstract][Full Text] [Related]
4. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries.
Sun CW; Falck JR; Okamoto H; Harder DR; Roman RJ
Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H339-50. PubMed ID: 10899074
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide.
Alonso-Galicia M; Drummond HA; Reddy KK; Falck JR; Roman RJ
Hypertension; 1997 Jan; 29(1 Pt 2):320-5. PubMed ID: 9039122
[TBL] [Abstract][Full Text] [Related]
6. Activation of protease-activated receptor-2 (PAR-2) elicits nitric oxide-dependent dilatation of the basilar artery in vivo.
Sobey CG; Cocks TM
Stroke; 1998 Jul; 29(7):1439-44. PubMed ID: 9660401
[TBL] [Abstract][Full Text] [Related]
7. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation.
Faraci FM; Sobey CG
Brain Res; 1999 Mar; 821(2):368-73. PubMed ID: 10064823
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms that produce nitric oxide-mediated relaxation of cerebral arteries during atherosclerosis.
Didion SP; Heistad DD; Faraci FM
Stroke; 2001 Mar; 32(3):761-6. PubMed ID: 11239199
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
10. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
Sobey CG; Faraci FM
Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
[TBL] [Abstract][Full Text] [Related]
11. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
12. Vasorelaxing effect of BAY 41-2272 in rat basilar artery: involvement of cGMP-dependent and independent mechanisms.
Teixeira CE; Priviero FB; Todd J; Webb RC
Hypertension; 2006 Mar; 47(3):596-602. PubMed ID: 16391173
[TBL] [Abstract][Full Text] [Related]
13. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Onoue H; Katusic ZS
Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
[TBL] [Abstract][Full Text] [Related]
14. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of 4-aminopyridine on responses of the basilar artery to nitric oxide.
Sobey CG; Faraci FM
Br J Pharmacol; 1999 Mar; 126(6):1437-43. PubMed ID: 10217538
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
17. Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats.
Chan MH; Chien TH; Lee PY; Chen HH
Psychopharmacology (Berl); 2004 Nov; 176(3-4):435-9. PubMed ID: 15118807
[TBL] [Abstract][Full Text] [Related]
18. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
Li PL; Jin MW; Campbell WB
Hypertension; 1998 Jan; 31(1 Pt 2):303-8. PubMed ID: 9453320
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
20. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
